Suppr超能文献

肾移植受者外周血管介入术后的对比剂后急性肾损伤

Postcontrast Acute Kidney Injury after Peripheral Vascular Interventions in Kidney Transplant Recipients.

作者信息

Lee Shin-Rong, Dardik Alan, Ochoa Chaar Cassius Iyad

机构信息

Department of Surgery, Yale University School of Medicine, New Haven, CT.

Division of Vascular Surgery, Yale University School of Medicine, New Haven, CT.

出版信息

Ann Vasc Surg. 2020 Oct;68:8-14. doi: 10.1016/j.avsg.2020.04.057. Epub 2020 May 16.

Abstract

BACKGROUND

Postcontrast acute kidney injury (PC-AKI) is a feared complication of peripheral vascular interventions (PVIs), associated with increased mortality. Whether kidney transplant recipients (KTRs) are at increased risk of PC-AKI after PVI is unknown. This study analyzes the perioperative outcomes of KTR following PVI, with emphasis on the incidence and risk factors for PC-AKI.

METHODS

The Vascular Quality Initiative files for PVI (2010-2018) were reviewed. Patients on dialysis were excluded. PC-AKI was defined by Vascular Quality Initiative as creatinine increase ≥0.5 mg/dL or new dialysis requirement. Characteristics of KTR and patients without kidney transplant were compared, and propensity score matching used to control for differences in baseline features. Multivariable logistic regression was used to define risk factors for PC-AKI, and survival was compared using Kaplan-Meier analysis.

RESULTS

A total of 58,014 procedures were analyzed, including 641 (1%) procedures for KTR. The incidence of PC-AKI in KTR was 2.8% compared with 0.9% in patients without kidney transplants. Baseline warfarin use (odds ratio [OR] = 4.7) and poor allograft function (OR = 4.0) were significantly associated with increased risk for PC-AKI in KTR. Compared with a matched group of patients without kidney transplant, KTR had similar risk of PC-AKI and were more likely to develop postop myocardial infarction (OR = 4.3) but had lower in-hospital mortality (OR = 0.22).

CONCLUSIONS

The incidence of PC-AKI in KTR is higher than the overall population undergoing PVI but is not elevated compared with propensity-matched patients without kidney transplant. PVI for peripheral artery disease in KTR is safe and associated with acceptable perioperative and long-term survival.

摘要

背景

造影剂后急性肾损伤(PC-AKI)是外周血管介入治疗(PVI)令人担忧的并发症,与死亡率增加相关。肾移植受者(KTR)在PVI后发生PC-AKI的风险是否增加尚不清楚。本研究分析了PVI后KTR的围手术期结局,重点关注PC-AKI的发生率和危险因素。

方法

回顾了血管质量倡议组织(Vascular Quality Initiative)的PVI文件(2010 - 2018年)。排除正在接受透析的患者。血管质量倡议组织将PC-AKI定义为肌酐升高≥0.5mg/dL或需要新的透析治疗。比较了KTR和未进行肾移植患者的特征,并使用倾向评分匹配来控制基线特征的差异。多变量逻辑回归用于确定PC-AKI的危险因素,并使用Kaplan-Meier分析比较生存率。

结果

共分析了58014例手术,其中包括641例(1%)KTR的手术。KTR中PC-AKI的发生率为2.8%,而未进行肾移植的患者为0.9%。基线使用华法林(比值比[OR]=4.7)和移植肾功能差(OR=4.0)与KTR发生PC-AKI的风险显著增加相关。与匹配的未进行肾移植患者组相比,KTR发生PC-AKI的风险相似,且更有可能发生术后心肌梗死(OR=4.3),但住院死亡率较低(OR=0.22)。

结论

KTR中PC-AKI的发生率高于接受PVI的总体人群,但与倾向评分匹配的未进行肾移植患者相比并未升高。KTR的外周动脉疾病PVI是安全的,且围手术期和长期生存率均可接受。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验